Single award · contract
Development of Mrna Vaccine to Licensure for the Prevention of COVID-19. CLIN 0001 - Pre-Award Cost, CLIN…
Award ID: 75A50120C00034
FY2020 · complete year · data as of 2026-07-12
A single federal award, with both ends of the trail linked.
$1.8B
Total award value
Award 75A50120C00034 is a contract from the Department of Health and Human Services, $1.8B obligated, FY2020 to FY2025, for Development of Mrna Vaccine to Licensure for the Prevention of COVID-19. CLIN 0001 - Pre-Award…. The work is performed in Massachusetts. It is classified as NAICS 325414 (Biological Product (except Diagnostic) Manufacturing) and PSC AN11 (Health R&D Services; Health Care Services; Basic Research). Source
Description
Development of Mrna Vaccine to Licensure for the Prevention of COVID-19. CLIN 0001 - Pre-Award Cost, CLIN 0002 - Development of Mrna Vaccine to Bla and CLIN 0003 - Domestic Manufacturing Scale-Out
Award details
Award typeContract
PIID75A50120C00034
Action date2020
Period62 mo
Awarding agencyDepartment of Health and Human Services →
RecipientOutside our Phase 1 contractor set: see methodology
Place of performanceMassachusetts →
CategoryNAICS 325414PSC AN11
Competed?Not recordedSource
Total (exact)$1,754,345,480
More from Department of Health and Human Services
awarded 2025$110.4B
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are Source; figures we calculate are Computed; links we infer (corporate parents, districts, similar contractors, connections between records) are Inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.